Pan Cancer T
Marconistraat 16
3029 AK Rotterdam
NL
Pan Cancer T
Foundation date
09/09/2020
Sector
#Biotechnology - TherapeuticsSubsector
Pan Cancer T is a biotech spin-out that builds further on 20 years of pioneering in adoptive cell therapy developed in the laboratories of Erasmus MC. We intend to lead the fight against solid cancers through T cell receptor (TCR) gene engineered T-cell therapy. Especially, those solid cancers for which there are limited treatment options and a poor prognosis.
Upcoming events
All events-
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
1505 '24
State of the Union by VIB & flanders.bio
Event by: flanders.bio & VIB -
2105 '24
IOT Solutions World Congress 2024
Event by: Fira Barcelona
Latest news
More news-
Labconsort and NEKTARI join forces for a more sustainable and social industry
Saturday April 20th 2024
Read more
-
BIO INX Complements Advisory Board with Distinguished Industry Leaders
Thursday April 18th 2024
Read more
-
Innovating today, creating tomorrow: the VIB Bio-Incubator
Thursday April 18th 2024
Read more
Jobs
More jobs-
23/04/24
Brussels
PhD Student Position: Fluorescent Biosensors in Neurodegenerative Diseases
Permanent
VIB -
23/04/24
Flemish Brabant
PhD Research position: multi-omics liquid biopsy platform to advance precision cancer medicine. (ref. BAP-2024-251)
Temporary
KU Leuven -
23/04/24
Flemish Brabant
Developer of a multi-omics liquid biopsy platform to advance precision cancer medicine (ref. BAP-2024-230)
Permanent
KU Leuven
More info?
Ellen Telleir
Communication Coordinator